Managing Appetite Loss in Patients with Depression

First-Line Approach: Mirtazapine

Mirtazapine is effective for patients with concurrent depression and appetite loss, making it an ideal choice for this specific population, with a recommended dose of 7.5-30 mg at bedtime 1
In a small retrospective study of patients with dementia, mirtazapine at 30 mg daily resulted in a mean weight gain of 1.9 kg after three months and 2.1 kg after six months, with about 80% of patients experiencing weight gain 3

Bupropion is the only antidepressant consistently shown to promote weight loss, making it unsuitable for patients with appetite loss, according to the American Gastroenterological Association 4
Paroxetine and amitriptyline are associated with a greater risk for weight gain compared to other antidepressants in their respective classes, as reported by the American Gastroenterological Association 4

Megestrol acetate (400-800 mg/day) is recommended as an effective pharmacological appetite stimulant, with improvement in appetite in approximately 25% of patients, according to the Praxis Medical Insights guidelines 1, 2
Dexamethasone (2-8 mg/day) offers a faster onset of action, making it suitable for patients with shorter life expectancy, as recommended by the Praxis Medical Insights guidelines 1, 2
Olanzapine (5 mg/day) may be considered for patients with concurrent nausea/vomiting, according to the Praxis Medical Insights guidelines 1

Provide emotional support during meals and ensure adequate feeding assistance, as recommended by the Praxis Medical Insights guidelines 2
Serve energy-dense meals to help patients meet nutritional requirements without increasing meal volume, according to the Praxis Medical Insights guidelines 1
Offer oral nutritional supplements when food intake is between 50-75% of usual intake, as recommended by the Praxis Medical Insights guidelines 1
Protein-enriched foods and drinks can improve protein intake in patients with poor appetite, according to the Praxis Medical Insights guidelines 1

Lower starting doses should be used for elderly patients with close monitoring for side effects, as recommended by the Praxis Medical Insights guidelines 2